Tuesday, November 4, 2025

Ian Mattioli named non-executive chair of healthcare tech and medicinal cannabis company

Ian Mattioli MBE, co-founder and CEO of Leicester wealth management group, Mattioli Woods, and founder and non-executive director of property business Custodian Property Income REIT Plc, has been appointed as non-executive chair of Kanabo Group, the patient focused healthcare technology and medicinal cannabis company.

David Tsur, who has served as Kanabo’s non-executive chair since the company’s admission to the London Stock Exchange in February 2021, will transition to deputy chair following Ian Mattioli’s appointment.

Mattioli has also taken part in the company’s £2.54 million fundraise.

David Tsur, deputy chair of Kanabo, said: “We are delighted to welcome Ian to the leadership team as we embark on a year of growth and expansion into new markets and services. His experience and understanding of London’s capital markets will be invaluable as we work to advance our strategic goals for the company.

“Since the company’s admission to the London Stock Exchange, we have achieved numerous significant milestones, including launching two medical cannabis products, building a comprehensive supply chain, acquiring The GP Service, and launching Treat-It, our innovative digital health platform for pain management.” 

Ian Mattioli MBE added: “I am delighted to join Kanabo as a chair and am impressed with the company’s commitment to personalised, accessible, and affordable healthcare. With its leading-edge technology and disruptive products, Kanabo is poised for significant growth in the digital health sector. I am keen to contribute my experience and knowledge to support Kanabo in its future success.”












Latest news

Related news

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close